Volumen 106 - año 2020

Número 09 (noviembre)

Página 545

Descargar el artículo completo:

Título / Title:

545 MANAGEMENT OF HYPERTENSION IN THE SARS-COV2ERA: CURRENT KNOWLEDGE AND FUTURE PERSPECTIVES Marianna Leopoulou, Dimitrios Chatzis

Resumen / Abstract:

The new SARS-CoV2 pandemic has ignited research worldwide, regarding its parameters. Hypertension, a comorbidity with high prevalence among patients with COVID-19 infection, is being extensively studied in the setting of the pandemic. Futhermore, RAAS inhibitors, drugs widely used among hypertensive patients, are on the spotlight regarding their safety during the COVID-19 era. In this review, we present current knowledge regarding both these aspects, as well as the new guidelines for the treatment of hypertensive patients during the pandemic.

Keywords: covid-19, sars-cov2, hypertension, comorbidities, RAAS inhibitors